This study included 232 patient with acne between the ages of 12 and 38 years old.
Acne vulgaris was graded using Global Acne Grading System (GAGS). This study was
undertaken to detect the impact of acne vulgaris and related factors that may influe
nce the
quality of life (QoL). QoL was measured using a combination of skin disease-specific
(Dermatological Life Quality Index (DLQI)) and acne-specific (Cardiff Acne Disability
Index (CADI)) questionnaires.
The results showed significant impairment of QoL in acne patients , females were
more affected than the males, there was no association between age and quality of life
impairment and the impact was proportional to the severity of acne, more severe acne is
associated with greater effect on quality of life.
This research aims to compare the therapeutic results of Silodosin, Doxozosin in patients with Benign Prostate Hyperplasia. A random sample was taken of (67) patients at Assad University Hospital in Lattakia, and was divided into two groups: the firs
t group was treated using Silodosin, and the second group was treated using Doxozosin. We studied the therapeutic development of patients after one month, three months, six months of treatment. Measurements were recorded (Ipss, Qol, Qmax) for both groups. Using appropriate statistical methods, we reached the following results:
Equality of the two groups of patients before applying the treatment.
The effectiveness of both drugs (Silodosin and Doxozosin) in the treatment of patients with Benign Prostate Hyperplasia, where results showed an improvement in therapeutic measurements (Ipss, Qol, Qmax) by time.
The effectiveness of the drug Silodosin in the treatment of patients with Benign Prostate Hyperplasia, compared with the efficacy of the drug Doxozosin, where results showed that therapeutic measurements (Ipss, Qol, Qmax) recorded a better improvement within the first group that was treated using Silodosin when compared with the results of measurements of the second group that was treated using Doxozosin
